GW Pharmaceuticals Competitors or Alternatives

GW Pharmaceuticals's top competitors include Zynerba, Zogenix and Ovid.

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

GW Pharmaceuticals's company profile

Justin Gover

CEO

86/100
1,000 - 5,000
$31M
$500M - 1B
1
GW Pharmaceuticals's Competitor - Zynerba logo

Armando Anido

Chairman & CEO

90/100
25 - 100
$75M
2
GW Pharmaceuticals's Competitor - Zogenix logo

Stephen J. Farr

President & CEO

84/100
250 - 500
$494.3M
$25M - 100M
3
GW Pharmaceuticals's Competitor - Ovid logo

Jeremy M. Levin

Chairman & CEO

87/100
60
$230.9M
$ < 1M
4
GW Pharmaceuticals's Competitor - InstyMeds logo

Brad Schraut

CEO

85/100
100 - 250
- -
$25M - 100M

GW Pharmaceuticals VS Zynerba

Zynerba has been one of GW Pharmaceuticals's top competitors. Zynerba is a Private company that was founded in 2007 in Devon, Pennsylvania. Like GW Pharmaceuticals, Zynerba also competes in the Pharmaceuticals sector. Compared to GW Pharmaceuticals, Zynerba has 1,134 fewer employees.

GW Pharmaceuticals VS Zogenix

Zogenix is seen as one of GW Pharmaceuticals's biggest rivals. Zogenix is a Private company that was founded in Emeryville, California in 2006. Like GW Pharmaceuticals, Zogenix also operates in the Biotechnology sector. Zogenix has 834 fewer employees vs. GW Pharmaceuticals.

GW Pharmaceuticals VS Ovid

Ovid is perceived as one of GW Pharmaceuticals's biggest rivals. Ovid was founded in New York, New York} in 2014. Like GW Pharmaceuticals, Ovid also competes in the Biotechnology space. Compared to GW Pharmaceuticals, Ovid generates $558.4M less revenue.

Frequently Asked Questions about GW Pharmaceuticals

  1. Who are GW Pharmaceuticals's top competitors?

    GW Pharmaceuticals's top 3 competitors are Zynerba, Zogenix, Ovid.
  2. Who is similar to GW Pharmaceuticals?

    Zynerba is the most similar to GW Pharmaceuticals. Zogenix and Ovid are also similar to GW Pharmaceuticals.
  1. Are GW Pharmaceuticals and Zynerba competitors?

    Yes, Zynerba is one of GW Pharmaceuticals’s top competitors.